In-hospital outcomes of ticagrelor versus clopidogrel in patients 75 years or older with acute coronary syndrome: findings from the Improving Care for Cardiovascular Disease in China (CCC)–Acute Coronary Syndrome Project

Author:

Yang Na1,Liu Jing1,Liu Jun1,Hao Yongchen1,Smith Jr Sidney C2,Huo Yong3,Fonarow Gregg C4,Ge Junbo5,Morgan Louise6,Ma Changsheng7ORCID,Han Yaling8,Zhao Dong1,Li Aihua,Li Bao,Xu Biao,Li Bin,Liu Bin,Wang Bin,He Yuanjun,Yu Bo,Yang Baisong,Luo Caidong,Wang Changqian,Liu Changyong,Liang Chuanliang,Gao Chuanyu,Lai Chunlin,Wang Chuntong,Zhang Chunyan,Wu Chunyang,Zhang Congliang,Cui Bin,Huang Lan,Peng Daoquan,Xu Dawen,Wu Di,Zhu Dongmei,Chai Dongsheng,Li Dongyan,Tang Fakuan,Xiao Jun,Zhao Fang,Huang Fangfang,Meng Fanju,Li Fengwei,Gan Fudong,Xu Gang,Sang Gengsheng,Ma Genshan,Zhang Guixia,Tao Guizhou,Li Guo,Chen Guoduo,Xin Guoqin,Li Guoqing,Fu Guosheng,Chen Guoxiong,Lin Hailong,Guo Haiping,Lin Haiyun,Jiang Hong,Liu Hong,Luan Hong,Zhang Hong,Deng Honghua,Li Hongwei,Wang Hongju,Liu Hualing,Dong Hui,Liu Hui,Zhang Huifang,Wang Huifeng,Chu Huimin,Xi Jiabin,Yang Jian,Ye Jianfeng,Li Jianhao,Tao Jianhong,Liu Jianwen,Yang JiaoMei,Ding Jiawang,Tong Jiayi,Chen Jie,Jiang Jie,Yang Jie,Li Jifu,Yan Jinchuan,Hu Jing,Xu Jing,Wang Jingfeng,Diao Jinglan,Zhao Jingshan,Wei Jinru,Yi Jinxing,Su Jinzi,Tang Jiong,Chen Jiyan,Yin Jiyan,Fan Juexin,Guan Jun,Ge Junbo,Liu Junming,Deng Junping,Fang Junping,Li Junxia,Chen Kaihong,Luo Kalan,Wu Keng,Hong Lang,Li Lang,Jiang Li,Wei Li,Meng Lijun,Ma Likun,Tang Lilong,Wang Lin,Wei Lin,Li Ling,Tao Ling,Yang Liqiong,Li Wei,Zhang Man,Chen Kaiming,Lai Meisheng,Tian Miao,Bai Mingcheng,Han Minghua,Chen Moshui,Liang Naiyi,Jia Nan,Bing Han,Qu Peng,Zhang Pengfei,Chen Ping,Hou Ping,Xie Ping,Zhang Ping,Dong Pingshuan,Wu Qiang,Xie Qiang,Zhong Qiaoqing,Wang Qichun,Su Qinfeng,Chang Rong,Lin Rong,Zhao Ruiping,Jia Shaobin,Nie Shaoping,Ye Shaowu,He Shenghu,Chen Shengyong,Ma Shixin,Li Shuangbin,Xin Shuanli,Xia Shudong,Zhang Shuhua,Qu Shuqiu,Ma Shuren,Wang Siding,Li Songbai,Luo Suxin,Liu Tao,Zhang Tao,Tuo Tian,Li Tianchang,Yang Tianlun,Du Tianmin,Wu Tongguo,Liu Wei,Mao Wei,Tuo Wei,Wang Wei,Jiang Weihong,Huang Weijian,Liu Weijun,Fan Weiqing,Xu Weiting,Lin Wenhua,Su Xi,Chen Xia,Zhang Xianan,Fu Xianghua,Yang Xiangjun,Zhao Xianxian,Ma Xiaochuan,Sun Xiaofei,Wang Xiaojun,Li Xiaolan,Li Xiaolei,Yang Xiaoli,Chen Xiaoping,Chen Xiaoping,Zhang Xiaoqin,Cheng Xiaoshu,Peng Xiaowei,Ma Xiaowen,Qi Xiaoyong,Feng Xiaoyun,Chen Ximing,Tang Xin,Tang Shengxing,Zhao Xingsheng,Chen Xiufeng,Li Xudong,Li Xue,Liu Xuebo,Peng Xuemei,Han Yaling,Wang Yan,Niu Yanbo,Yu Yang,Zheng Yang,Wang Yanli,Zheng Yanlie,Guo Yansong,Yang Yanzong,Huang Yi,Liu Yin,Guo Ying,Luo Yingchao,Hao Yinglu,Sun Yingxian,Lin Yingzhong,Ma Yitong,Guo Yong,Li Yong,Li Yongdong,Zhang Yonglin,Jin Yuanzhe,Li Yue,Huang Yuehua,Sun Yuemin,Yang Yuheng,Zhu Yuhua,Shi Yuhuan,Zhao Yulan,Hou Yuqing,Zheng Zeqi,Xu Zesheng,Ouyang Zewei,He Zeyuan,Lv Zhan,Li Zhanquan,He Zhaofa,Ji Zheng,Zhang Zheng,Ji Zhenguo,Su Zhenqi,Yang Zhenyu,Ou Zhihong,Yang Zhijian,Yang Zhiming,Wang Zhirong,Song Zhiyuan,Wang Zhongshan,Yuan Zuyi,

Affiliation:

1. Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases Department of Epidemiology, Beijing Anzhen Hospital, , Beijing, China

2. University of North Carolina Division of Cardiology, , Chapel Hill, NC, USA

3. Peking University First Hospital Department of Cardiology, , Beijing, China

4. Geffen School of Medicine at University of California Division of Cardiology, , Los Angeles, CA, USA

5. Fudan University Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, , Shanghai, China

6. International Quality Improvement Department, American Heart Association , Dallas, TX, USA

7. Capital Medical University Department of Cardiology, Beijing An Zhen Hospital, , Beijing, China

8. Cardiovascular Research Institute and Department of Cardiology , General Hospital of Northern Theater Command, Shenyang, Liaoning, China

Abstract

Abstract Background The evidence for the comparative effectiveness and safety of ticagrelor versus clopidogrel in older patients with acute coronary syndrome (ACS) is limited, especially in the acute phase of ACS. This study aimed to compare the in-hospital outcomes of ticagrelor versus clopidogrel in older patients with ACS. Methods Hospitalised ACS patients aged ≥75 years who were recruited to the Improving Care for Cardiovascular Disease in China-ACS project between November 2014 and December 2019 and received aspirin and P2Y12 receptor inhibitors within 24 h after first medical contact were included. The primary outcomes were in-hospital major adverse cardiovascular events (MACE) and major bleeding. Multivariable Cox regression was performed to evaluate the comparative effectiveness and safety of ticagrelor and clopidogrel. Inverse probability of treatment weighting (IPTW) and propensity score matching analyses were performed to evaluate the robustness of the results. Results Of 18,244 ACS patients, 18.5% received ticagrelor. Multivariable-adjusted analysis revealed comparable risks of in-hospital MACE between patients receiving ticagrelor and clopidogrel (hazard ratio [HR] 1.12, 95% confidence interval [CI] 0.92–1.35). However, ticagrelor use was associated with 45% higher risk of in-hospital major bleeding compared with clopidogrel use (HR 1.45, 95% CI 1.09–1.91). Similar results were found in the IPTW analysis. Conclusions ACS patients aged ≥75 years receiving ticagrelor during the acute phase had similar risk of in-hospital MACE, but higher risk of in-hospital major bleeding compared with those receiving clopidogrel. More evidence is needed to guide the use of P2Y12 receptor inhibitors during hospitalisation in older patients with ACS. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT02306616.

Funder

Pfizer

Publisher

Oxford University Press (OUP)

Subject

Geriatrics and Gerontology,Aging,General Medicine

Reference31 articles.

1. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;Circulation,2013

2. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Amsterdam;J Am Coll Cardiol,2014

3. Guideline for the diagnosis and management of patients with non-ST-elevation acute coronary syndrome;Chinese Society of Cardiology;Chin J Cardiol Dis,2017

4. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC);Ibanez;Eur Heart J,2018

5. Guideline for the diagnosis and management of ST-elevation myocardial infarction (2019);Chinese Society of Cardiology;Chin J Cardiol Dis,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3